Subscribe To

Price Alert Latest News Economic Calendar News

ORGO / Organogenesis Holdings Inc. (ORGO) Q4 2022 Earnings Call Transcript

Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q4 2022 Earnings Conference Call March 1, 2023 5:00 PM ET Company Participants Gary Gillheeney - President and Chief Executive Officer Dave Francisco - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Operator Welcome, ladies and gentlemen to the Fourth Quarter and Fiscal Year 2022 Earnings Conference Call for Organogenesis Holdings Inc. [Operator Instructions] Please note that this conference call is being recorded and that the recording will be available on the company's website for replay shortly. Before we begin, I would like to remind everyone that our remarks today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties that could cause actual results to differ materially from those indicated, including the risks and uncertainties described in the company's filings with the Securities and Exchange Commission, including Item 1A Risk Factors of the company's most recent annual report and its subsequently filed quarterly reports. Read More

Demo Live Account See Partner Details

Content Topics

Organogenesis

Holdings

Inc

ORGO

2022

Earnings

Call

orgo

Transcript

Stock

Posted: Mar 1 2023, 22:17

Author Name: Seeking Alpha

ORGO News

By The Motley Fool
September 28, 2023

Why Shares of Organogenesis Holdings Are Up Thursday

Organogenesis focuses on advanced wound products. The company's second-quarter revenue and net income were down year over year.

By The Motley Fool
May 24, 2023

Why Shares of Organogenesis Climbed Wednesday

An analyst updated Organogenesis' price target. Competitor Integra LifeSciences said Tuesday it was recalling a product.

By The Motley Fool
May 11, 2023

Why Shares of Organogenesis Holdings Jumped Thursday

Organogenesis said it expects sales to rise between 1% and 3% this year. The company said revenue rose by 10% year over year in the first quarter.

By Seeking Alpha
May 10, 2023

Organogenesis Holdings Inc. (ORGO) Q1 2023 Earnings Call Transcript

Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q1 2023 Earnings Conference Call May 10, 2023 5:00 PM ET Company Participants Gary Gillheeney - President a

By GlobeNewsWire
April 10, 2023

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023

CANTON, Mass., April 10, 2023 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the d

By Seeking Alpha
March 1, 2023

Organogenesis Holdings Inc. (ORGO) Q4 2022 Earnings Call Transcript

Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q4 2022 Earnings Conference Call March 1, 2023 5:00 PM ET Company Participants Gary Gillheeney - President

By Seeking Alpha
November 9, 2022

Organogenesis Holdings Inc. (ORGO) Q3 2022 Earnings Call Transcript

Organogenesis Holdings Inc. (NASDAQ:ORGO ) Q3 2022 Earnings Conference Call November 9, 2022 5:00 PM ET Corporate Participants Gary Gillheeney - Presi

By The Motley Fool
August 10, 2022

Why Organogenesis Stock Is Tumbling Today

It didn't make as much money in the second quarter as investors were hoping.

Risk Disclosure:

Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
We would like to remind you that the data contained in this website is not necessarily real-time nor accurate.
The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. We and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of us and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. We may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.